- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05871645
Placenta Accreta Spectrum Management: Uterine Preservation Using JSICA Technique - Retrospective Cross-Sectional Study
June 5, 2023 updated by: Amanda Rumondang, Dr Cipto Mangunkusumo General Hospital
The goal of this study is to present the Jakarta Surgical Uterine Conservation (JSICA) technique and its perioperative outcomes in Placenta Accreta Spectrum patients.
Participants are all patients undergoing standard hysterectomy or the Jakarta Surgical Uterine Conservation (JSICA) technique.
Researchers will compare both groups to see if there are any differences in the perioperative outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study uses data from Cipto Mangunkusumo General Hospital's Placenta Accreta Case Register.
This register includes all patients with a confirmed placenta accreta spectrum diagnosis.
Data collected includes demographic characteristics, risk factors, surgery characteristics, and perioperative outcomes.
In this study, researchers would like to evaluate the perioperative outcomes of the JSICA technique in comparison to a standard hysterectomy.
Study Type
Interventional
Enrollment (Actual)
323
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Maternal Fetal Medicine Division, Obstetric Gynecology Department Cipto Mangunkusumo General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria for JSICA:
- Focal accreta invasion ( < 50% anterior wall)
- Anterior invasion
- No parametrial or bladder invasion
- Residual tissue or healthy myometrium min 3 cm above the OUI or cervix
- Good uterine contraction post-repair (with or without compression sutures)
- Hemodynamically stable
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Jakarta Surgical Uterine Conservation (JSICA) technique
Cipto Mangunkusumo General Hospital's novel uterine preservation technique based on standard procedure
|
a. Identifying the placenta accrete site; b.
Meticulous dissection to create a bladder flap; c.
Incision 1 cm above the placenta accrete; d.
Fetal delivery; e. Bottom incision to resect the placenta; f.
Placental delivery; g.
Uterus without placenta; h.
The resection area is approximated using interrupted horizontal mattress suture; i.
The continuous suture used to close all incision areas; j.
Evaluation of uterine contraction
|
|
Active Comparator: Standard Hysterectomy
Surgery to remove the uterus
|
The main types of hysterectomy are abdominal, vaginal, and laparoscopic hysterectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative bleeding
Time Frame: Perioperative
|
Intraoperative bleeding in this study was measured by the amount of blood loss (cc) and classified into < 1.000 cc, 1.000-1.500
cc, and > 1.500 cc. .
|
Perioperative
|
|
Operation duration
Time Frame: Perioperative
|
The operation duration was the time interval from skin incision to closure (hours) and classified into < 3 hours and > 3 hours.
|
Perioperative
|
|
Number of Patients Admitted to ICU
Time Frame: 24 hours
|
ICU admission was identified by the documentation of number of patients' admission to the ICU
|
24 hours
|
|
Rate of Intraoperative complications
Time Frame: Intraoperative
|
Rate of intraoperative complications were identified by the documentation of injury to adjacent structures (bladder or ureter) or a need for transfusion.
|
Intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative Bleeding in JSICA compared to hysterectomy
Time Frame: Perioperative
|
Intraoperative bleeding in this study was measured by the amount of blood loss (cc) and classified into < 1.000 cc, 1.000-1.500
cc, and > 1.500 cc in comparison of JSICA to hysterectomy
|
Perioperative
|
|
Operation duration in JSICA compared to hysterectomy
Time Frame: Perioperative
|
The operation duration was the time interval from skin incision to closure (hours) and classified into < 3 hours and > 3 hours in comparison of JSICA to hysterectomy
|
Perioperative
|
|
Number of Patients Admitted to ICU in JSICA compared to hysterectomy
Time Frame: 24 hours
|
ICU admission was identified by the documentation of number of patients' admission to the ICU in comparison of JSICA to hysterectomy
|
24 hours
|
|
Rate of Intraoperative complications in JSICA compared to hysterectomy
Time Frame: Perioperative
|
Rate of intraoperative complications were identified by the documentation of injury to adjacent structures (bladder or ureter) or a need for transfusion in comparison of JSICA to hysterectomy
|
Perioperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
February 28, 2022
Study Registration Dates
First Submitted
February 27, 2023
First Submitted That Met QC Criteria
May 20, 2023
First Posted (Actual)
May 23, 2023
Study Record Updates
Last Update Posted (Actual)
June 7, 2023
Last Update Submitted That Met QC Criteria
June 5, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-05-0541
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placenta Accreta
-
Adana City Training and Research HospitalCompletedPlacenta Accreta Spectrum | Placenta PreviaTurkey (Türkiye)
-
Cairo UniversityNot yet recruiting
-
Assiut UniversityNot yet recruitingPlacenta Accreta SpectrumEgypt
-
Gaziantep City HospitalNot yet recruiting
-
Sohag UniversityNot yet recruitingPlacenta Accreta Spectrum | Placenta Accreta | Placenta Previa
-
Assiut UniversityNot yet recruitingPlacenta Accreta Management
-
Başakşehir Çam & Sakura City HospitalCompletedPlacenta Accreta Spectrum | Placenta Accreta / PercretaTurkey
-
Kasr El Aini HospitalUnknownPlacenta Accreta in Placenta Previa Anterior
-
Ain Shams Maternity HospitalCompleted
-
Maternal and Child Health Hospital of FoshanWithdrawnPlacenta Accreta SpectrumChina
Clinical Trials on Jakarta Surgical Uterine Conservation (JSICA) Technique
-
Colin D. Weekes, M.D., PhDNovartisTerminatedPancreas Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States